Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biostar Pharmaceuticals Inc (NASDAQ:BSPM)

0.6401
Delayed Data
As of Sep 02
 -0.0499 / -7.23%
Today’s Change
0.60
Today|||52-Week Range
2.16
-45.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$10.7M

Company Description

BioStar Pharmaceuticals, Inc., develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The company's products include AoXing Oleanlic Acid Capsule (treatment for Hepatitis B), Danshen Granule (treatment for coronory heart disease, myocarditis and angina pectoris), GanWang (treatment for colds, runny nose, sore throat, headache and fever), Taohuasan (treatment for bronchial congestion and coughs) and Tianqi Dysmenorrhea Capsule (treatment for dysmenorrhea). BioStar Pharmaceuticals was founded on March 27, 2007 and is headquartered in Xianyang, China.

Contact Information

BioStar Pharmaceuticals, Inc.
No. 588 Shiji Xi Avenue
Xianyang Shaanxi 712046
P:862933685888
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Rong Hua WangChairman & Chief Executive Officer
Zheng Hong WangChief Operating Officer
Qing Hua LiuChief Financial Officer & Director
Gong ShuangSecretary & Administration Director
Xiaohui ZhengChief Scientist